These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23572384)

  • 1. Destination therapy--time for a paradigm change in heart failure therapy.
    Wilhelm MJ; Ruschitzka F; Falk V
    Swiss Med Wkly; 2013; 143():w13729. PubMed ID: 23572384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical Circulatory Support: Heart Failure Therapy "in Motion".
    Ensminger SM; Gerosa G; Gummert JF; Falk V
    Innovations (Phila); 2016; 11(5):305-314. PubMed ID: 27828806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients on continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Naka Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1606-14. PubMed ID: 25260275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared Care to Destination Therapy Left Ventricular Assist Device Site: a Novel Strategy to Start a Successful Mechanical Circulatory Support Program.
    Shah M; Hafeez Y; Burns P; Toyoda Y; Moshiyakhov M; Neary M; Ross R; Chichetti J; Muzaffar A; Barn K
    Curr Cardiol Rep; 2021 Jul; 23(8):112. PubMed ID: 34264422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the art: implantable ventricular assist devices.
    Lahpor JR
    Curr Opin Organ Transplant; 2009 Oct; 14(5):554-9. PubMed ID: 19667990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on mechanical circulatory support for heart failure therapy.
    Toeg HD; Al-Atassi T; Garcia JP; Ruel M
    Curr Opin Cardiol; 2014 Mar; 29(2):167-73. PubMed ID: 24395064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actual role of cardiocirculatory assistance in heart-failure treatment as destination therapy and bridge to life.
    Bonacchi M; Harmelin G; Sani G
    Heart Fail Clin; 2014 Jan; 10(1 Suppl):S13-25. PubMed ID: 24262349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical circulatory support for destination therapy.
    Tozzi P; Hullin R
    Swiss Med Wkly; 2016; 146():w14267. PubMed ID: 26945160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New role of mechanical assist device as bridge to transplant: USA perspective.
    Mohamed A; Mehta N; Eisen HJ
    Curr Opin Organ Transplant; 2017 Jun; 22(3):231-235. PubMed ID: 28441157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?].
    Olsen PS; Sander K; Hansen PB; Mortensen SA; Gustafsson F; Boesgaard S
    Ugeskr Laeger; 2007 Sep; 169(39):3287-9. PubMed ID: 17953887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.